What Wit Can Teach Us About Ovarian Cancer and Clinical Trials

On screen

Wit — first a Pulitzer Prize–winning play by Margaret Edson, later an HBO film — follows Vivian Bearing, a sharp, formidable professor of English literature who is diagnosed with advanced ovarian cancer. Much of the story takes place as she undergoes an intensive, experimental course of chemotherapy as part of a clinical trial, and it looks unflinchingly at what that experience is like from the inside. The film's honesty makes it a thoughtful lens on two subjects: ovarian cancer and what clinical trials really are.

The reality

Ovarian cancer. According to the National Cancer Institute, ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer form in the same kind of tissue and are treated in the same way. NCI notes a detail that echoes Vivian's story directly: these cancers are often advanced at diagnosis. Less common types include ovarian germ cell tumors and ovarian low malignant potential (borderline) tumors. Vivian's "advanced" diagnosis reflects a real and common reality for this group of cancers.

Clinical trials. NCI explains that clinical trials are research studies that test how well new medical approaches work in people. They test new ways to find, prevent, and treat cancer, and they also help doctors improve quality of life by testing ways to manage side effects. NCI describes several types — treatment, prevention, screening, and supportive/palliative care trials — with most cancer trials being treatment studies involving people who have cancer. NCI also notes that thanks to results of past cancer clinical trials, people are living longer lives, and that taking part adds to knowledge that can help future patients.

What the story gets right — and what to remember

Wit captures two accurate truths: that ovarian cancer is often found at an advanced stage, and that clinical trials involve real people receiving treatments that are still being studied. The film is candid about how demanding an experimental treatment can be.

At the same time, a single character's experience is not a stand-in for anyone else's. Trials, treatments, and outcomes vary enormously, and NCI emphasizes safety and informed choice throughout its clinical trials information. Nothing here is medical advice, and Vivian's story should not be read as a guide to any real diagnosis or trial — those decisions belong with a person and their healthcare team.

Awareness, screening & prevention

NCI does maintain both prevention and screening information for ovarian, fallopian tube, and primary peritoneal cancers, and it connects ovarian cancer risk to inherited factors, pointing to information on BRCA gene changes and genetic testing. Because these cancers are often advanced at diagnosis, understanding risk — including family history and inherited gene changes — is part of the conversation a person may want to have with their healthcare team. NCI's dedicated screening and prevention pages can help a care team tailor guidance to an individual.

Turning a story into something useful

Wit gives audiences a rare, honest look at advanced ovarian cancer and the experience of an experimental trial. Learning the real facts — that ovarian cancer is often found late, that clinical trials are carefully designed research studies, and that past trials have helped people live longer — turns a moving drama into genuine understanding. Sharing that knowledge, and supporting free cancer education, helps keep clear information available to anyone weighing these questions.

Questions to ask a healthcare team

• Why is ovarian cancer often found at an advanced stage?
• What is a clinical trial, and what are the different types?
• How would I learn whether a clinical trial might be an option for my situation?
• Where can I find reliable information about ovarian cancer risk and genetic testing?